tiprankstipranks
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM

Axsome Therapeutics (AXSM) Similar Stocks

Compare
2,107 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Axsome Therapeutics
$126.79
$6.18B
60.14%
17 Buy
0 Hold
0 Sell
Strong Buy
ACADIA Pharmaceuticals
$16.79
$2.80B
12.35
-3.42%
9 Buy
6 Hold
0 Sell
Moderate Buy
Neurocrine
$111.92
$11.16B
34.01
-18.26%
17 Buy
5 Hold
0 Sell
Strong Buy
Prothena
$12.97
$698.14M
-49.96%
6 Buy
2 Hold
0 Sell
Strong Buy
Intra-Cellular Therapies
$131.65
$14.00B
90.81%
4 Buy
9 Hold
0 Sell
Moderate Buy
SAGE Therapeutics
$8.10
$498.00M
-56.66%
2 Buy
14 Hold
1 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AXSM
Axsome Therapeutics
129.17
51.82
66.99%
ACAD
ACADIA Pharmaceuticals
17.23
-0.61
-3.42%
NBIX
Neurocrine
115.60
-24.65
-17.58%
PRTA
Prothena
12.97
-12.43
-48.94%
ITCI
Intra-Cellular Therapies
131.70
63.73
93.76%
SAGE
SAGE Therapeutics
8.10
-10.59
-56.66%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis